A Medicine for Weakness Has Reached the Black Market, Even if It Has Not Been Approved.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
The experimental weight loss drug retatrutide, which has not yet been approved by any regulator, is already being massively counterfeited and sold through social networks, gyms and beauty salons.
An experimental medicine for weakness, retatrutide, has reached the black market, although the substance has not been approved for use in humans by any regulatory authority in the world.
The demand for retatrutide, an experimental medicine for weakness developed by Eli Lilly, led to the emergence of a black market in the UK. Products that claim to be retatrutide are sold through social networks, sports halls and salons, although the substance is not yet authorised for use in humans, according to Mediafax. Counterfeit versions of retatrutide, known [...]
The growing demand for retatrutide, an experimental drug for weakening developed by pharmaceutical company Eli Lilly, has led to the expansion of a black market with products claiming to be the drug, although it has not been approved for use in people of no authority.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
